Is it the right time to buy pharma stocks?

The Nifty Pharma Index is down 27% over the past year amid pricing and regulatory pressure

Published 2 years ago on Sep 04, 2019 1 minute Read

Sailesh Raj Bhan, Deputy CIO, Reliance Mutual Fund

When a sector comes out of three-four tough years, it takes a year or two to nurse it back to health. The same applies to pharma. A year ago, only 25-30% pharma companies were doing well, now it’s around 50-60%. There are two factors that have turned favourable in the past year. Firstly, the US generic market has stabilised with reduction in price correction and improvement in profitability. Secondly, the share of profit from the US generic business is much lower co


You don’t want to be left behind. Do you?

Our work is exclusively for discerning readers. To read our edgy stories and access our archives, you’ve to subscribe